Frontiers in Oncology (Sep 2022)

18F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer

  • Jianyi Qiao,
  • Jianyi Qiao,
  • Xin Zhang,
  • Xin Zhang,
  • Ming Du,
  • Ming Du,
  • Pengyuan Wang,
  • Pengyuan Wang,
  • Jun Xin,
  • Jun Xin

DOI
https://doi.org/10.3389/fonc.2022.974934
Journal volume & issue
Vol. 12

Abstract

Read online

PurposeTo investigate the ability of a PET/CT-based radiomics nomogram to predict occult lymph node metastasis in patients with clinical stage N0 non-small cell lung cancer (NSCLC).Materials and methodsThis retrospective study included 228 patients with surgically confirmed NSCLC (training set, 159 patients; testing set, 69 patients). ITKsnap3.8.0 was used for image(CT and PET images) segmentation, AK version 3.2.0 was used for radiomics feature extraction, and Python3.7.0 was used for radiomics feature screening. A radiomics model for predicting occult lymph node metastasis was established using a logistic regression algorithm. A nomogram was constructed by combining radiomics scores with selected clinical predictors. Receiver operating characteristic (ROC) curves were used to verify the performance of the radiomics model and nomogram in the training and testing sets.ResultsThe radiomics nomogram comprising six selected features achieved good prediction efficiency, including radiomics characteristics and tumor location information (central or peripheral), which demonstrated good calibration and discrimination ability in the training (area under the ROC curve [AUC] = 0.884, 95% confidence interval [CI]: 0.826-0.941) and testing (AUC = 0.881, 95% CI: 0.8031-0.959) sets. Clinical decision curves demonstrated that the nomogram was clinically useful.ConclusionThe PET/CT-based radiomics nomogram is a noninvasive tool for predicting occult lymph node metastasis in NSCLC.

Keywords